title: Incidence and outcome of Yersinia enterocolitica infection in thalassemic patients.
authors.affiliation: USL 5, Ozieri-Sassari, Italy.
authors.forename: G B
authors.initials: GB
authors.lastname: Cherchi
authors.forename: S
authors.initials: S
authors.lastname: Cossellu
authors.forename: L
authors.initials: L
authors.lastname: Pacifico
authors.forename: D
authors.initials: D
authors.lastname: Gallisai
authors.forename: A
authors.initials: A
authors.lastname: Ranucci
authors.forename: S
authors.initials: S
authors.lastname: Zanetti
authors.forename: G
authors.initials: G
authors.lastname: Fadda
authors.forename: C
authors.initials: C
authors.lastname: Chiesa
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D002443:Ceftriaxone / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004751:Enteritis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D011446:Prospective Studies; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D015009:Yersinia Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology*; D015008:Yersinia enterocolitica; D017086:beta-Thalassemia / Q000150:complications*
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D002443:Ceftriaxone; D015662:Trimethoprim, Sulfamethoxazole Drug Combination